Preprescription genotyping: not yet ready for prime time, but getting there.
Roden
D M
DM
Brown
N J
NJ
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D004351:Drug Resistance / Q000235:genetics*; D014644:Genetic Variation; D005838:Genotype; D006333:Heart Failure / Q000188:drug therapy / Q000201:enzymology*; D006801:Humans; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D007703:Peptidyl-Dipeptidase A